Le Teuff, Gwénaël http://orcid.org/0000-0003-3292-0939
Cozic, Nathalie
Boyer, Jean-Christophe
Boige, Valérie
Diasio, Robert B.
Taieb, Julien http://orcid.org/0000-0002-9955-4753
Meulendijks, Didier
Palles, Claire http://orcid.org/0000-0002-9670-2263
Schwab, Matthias
Deenen, Maarten
Largiadèr, Carlo R. http://orcid.org/0000-0002-0889-8922
Marinaki, Anthony
Jennings, Barbara A.
Wettergren, Yvonne http://orcid.org/0000-0001-8660-7169
Di Paolo, Antonello
Gross, Eva
Budai, Barna
Ackland, Stephen P.
van Kuilenburg, André B. P.
McLeod, Howard L. http://orcid.org/0000-0002-9004-9232
Milano, Gérard http://orcid.org/0000-0003-2478-0040
Thomas, Fabienne
Loriot, Marie-Anne
Kerr, David http://orcid.org/0000-0001-7811-6722
Schellens, Jan H. M.
Laurent-Puig, Pierre http://orcid.org/0000-0001-8475-5459
Shi, Qian
Pignon, Jean-Pierre
Etienne-Grimaldi, Marie-Christine
,
Article History
Received: 12 July 2023
Revised: 30 October 2023
Accepted: 23 November 2023
First Online: 15 January 2024
Competing interests
: GM reports consulting fees from Servier. JHM Schellens reports patents on oral taxanes. MS reports payment and honoraria for lectures for CED Service GmbH. VB reports consulting fees from Merck, Serono, Bayer, Roche, Eisai and BMS. Q Shi reports grants from Janssen, BMS, Genetech, Novartis, Celgene and fees from Regeneron Pharmaceuticals and Chugai Pharmaceuticals. MC Etienne-Grimaldi reports honoraria for lectures for AMGEN. All other authors report no conflicts of interest.
: Included clinical studies were conducted in accordance with the Declaration of Helsinki.